{"id":4408,"date":"2025-03-31T18:12:07","date_gmt":"2025-03-31T18:12:07","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/thiotepa-txt\/"},"modified":"2025-03-31T18:12:07","modified_gmt":"2025-03-31T18:12:07","slug":"thiotepa-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/thiotepa-txt\/","title":{"rendered":"Thiotepa.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3>  Alkylating antineoplastic agent <H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3> IM, bladder and intracavitary instillations:   60 mg in single or divided doses Intrathecal: maximum 10 mg   Other doses depend on indication or local   protocol <H3>  PHARMACOKINETICS    <\/H3> <LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 189.2 <\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 10\u201340 <\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : &lt;2 <\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp : 0.3\u20131.6 <\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp : 2.4 <H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4> <LI> 20 to 50  &amp;nbsp &amp;nbsp : IM: Use a reduced dose with caution <LI> 10 to 20  &amp;nbsp &amp;nbsp : IM: Use a reduced dose with caution <LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : IM: Use a reduced dose with caution <H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3> <LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp: Unknown dialysability. Dose as in GFR &lt;10 mL\/min <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Dialysed. Dose as in GFR<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/ min <LI>HDF\/high flux  &amp;nbsp : Dialysed. Dose as in GFR<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/ min <LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp: Dialysed. Dose as in GFR=10\u2013 20 mL\/min <H3> IMPORTANT DRUG INTERACTIONS  <\/H3> Potentially hazardous interactions with other drugs\n<li>Antipsychotics: avoid concomitant use   with clozapine Avoid concomitant use with other   myelosuppressive agents <H3> ADMINISTRATION  <\/H3> <H4> Reconstition<\/H4> 1.5 mL water for injection   <H4>  Route  <\/H4> IV, IM, intrathecal (can be administered   directly into pleural, pericardial or peritoneal cavities and as a bladder instillation) <H4>  Rate of Administration  <\/H4> \u2013 <H4>Comments<\/H4> \u2013 <H4>  OTHER INFORMATION  <\/H4> Haemorrhagic cystitis has occurred   Metabolised in liver to triethylene   phosphoramide (TEPA). Only traces of unchanged thiotepa and (TEPA) are excreted in the urine, together with a large proportion of metabolites (60% within 72 hours) .<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Alkylating antineoplastic agent DOSE IN NORMAL RENAL FUNCTION<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4408","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4408"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4408\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}